Benzinga··Vandana SinghBioNTech Plummets 14% as Co-Founders Exit for New mRNA Venture
BioNTech shares plunge 14% as co-founders announce exit plan, with company cutting 2026 revenue guidance due to declining COVID demand.
BMYCELGrPFEMRNABNTXguidance reductionPhase 3 trials